Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
---|
03/02/1999 | US5877293 CDR grafted anti-CEA antibodies and their production |
03/02/1999 | US5877285 Lymphocyte specific chemokines; for diagnostic kits; antiproliferative agents; anticancer agents; autoimmune disorders |
03/02/1999 | US5877281 Since del-1 is expressed in endothelial cells and certain cancer cells, it may be useful as an endothelial cell and tumor marker. in addition, the ability of del-1 protein to inhibit vascular formation provides for its use as an |
03/02/1999 | US5877273 Antigenic polypeptide mycobacteria; for production of antibodies; for simple diagnosis of tuberculosis and leprosy |
03/02/1999 | US5877203 Treatment for atherosclerosis and other cardiovascular and inflammatory diseases |
03/02/1999 | US5877179 Cystic fibrosis |
03/02/1999 | US5877029 Using antibody against insulin-like growth factor |
03/02/1999 | US5877028 Immunochromatographic assay device |
03/02/1999 | US5877027 Decomposing a natural quartz powder with hydrofluoric acid, evaporating to dryness, heating the residue with a salt or hydroxide of an alkali metal to effect fusion, dissolving in an acid solution and analyzing quantitatively |
03/02/1999 | US5877025 Glycated proteins assay |
03/02/1999 | US5877016 Human trk receptors and neurotrophic factor inhibitors |
03/02/1999 | US5877015 APP770 mutant in alzheimer's disease |
03/02/1999 | US5877007 Method of screening for protein inhibitors and activators |
03/02/1999 | US5876997 Phytase |
03/02/1999 | US5876978 Concurrent amplification of target and control cdna in presence of mutant competitive templates, comparing relative band densities; for analysis of small specimens |
03/02/1999 | US5876973 Method for making antibodies which specifically bind to glial growth factors |
03/02/1999 | US5876972 Nucleic acid molecules coding for tumor suppressor proteins and methods for their isolation |
03/02/1999 | US5876970 Expressing and recovering recombinantly produced surfactant protein-c, treating with activated derivative of fatty acid, thus forming fatty acid thioesters at cysteine residues; for stable, nonaggregating therapy for premature infants |
03/02/1999 | US5876967 Fibroblast growth factor homologous factor-2 and methods of use |
03/02/1999 | US5876965 Nucleic acid encoding ARF-19, a novel regulator of the mammalian cell cycle |
03/02/1999 | US5876963 Human nucleotide pyrophosphohydrolase |
03/02/1999 | US5876958 Assays of cells expressing human calcium channels containing α1 β subunits |
03/02/1999 | US5876957 Accurately applying predetermined amount of indicator system and oxidase or peroxidase to substrate and test pad using nozzle and attached flexible restrictor |
03/02/1999 | US5876955 Endotoxin stabilizing agent, endotoxin composition and method for assaying endotoxin |
03/02/1999 | US5876954 Cytotoxic factor as is associated with multiple sclerosis, its detection and its quantification |
03/02/1999 | US5876950 Monoclonal antibodies specific for different epitopes of human GP39 and methods for their use in diagnosis and therapy |
03/02/1999 | US5876948 Screening methods to identify neurotoxin inhibitors |
03/02/1999 | US5876947 Monospecific antibody reactive with Fibrinogen and fibrinopeptide B |
03/02/1999 | US5876946 High-throughput assay |
03/02/1999 | US5876945 Immunoassay using reporter linked antibody against processed d1 polypeptide important in photosynthesis to detect enzymatic activity; low signal is indicator of enzyme inhibitor |
03/02/1999 | US5876944 Method for amplification of the response signal in a sandwich immunoassay |
03/02/1999 | US5876943 Antigenic polypeptide produced by genetic engineering for use in diagnosis of and vaccines to peptic ulcers and stomach cancer |
03/02/1999 | US5876936 Nucleic acid sequencing with solid phase capturable terminators |
03/02/1999 | US5876935 Analyte detection for whole blood using heterogenous immunoassay; complexing analyte with first binding reagent labeled with aequorin and second reagent immobilized to magnetic spheres; activating luminescence |
03/02/1999 | US5876932 Method for gene expression analysis |
03/02/1999 | US5876931 Identification of genes |
03/02/1999 | US5876928 Method of detecting and characterizing a nucleic acid or a sequence of the latter, and enzymatic reactant for the application of this method |
03/02/1999 | US5876925 Generating bacteriophage display library expressing heterologous protein which bonds antigen on magnetically labeled cells; incubating with labeled and unlabeled cells, separating out label cells, isolating dna |
03/02/1999 | US5876920 Screening for vircides and viral suppressors by contacting infected cell with agent, determining if suppression of prenylation of proteins; against hepatitis virus |
03/02/1999 | US5876732 Envelope protein |
03/02/1999 | US5876731 Candidate vaccines against hiv-1 and which are useful in diagnostic application. |
03/02/1999 | US5876723 Purified human papillomavirus type 33 (HPV-33) peptides as an immunogenic composition |
03/02/1999 | US5876718 Using antibodies which bind to protein |
03/02/1999 | US5876712 Immune reactivity to HER-2/neu protein for diagnosis and treatment of malignancies in which the HER-2/neu oncogene is associated |
03/02/1999 | US5876694 Azavesamicols |
03/02/1999 | US5876671 Sonication standard laboratory module |
03/02/1999 | US5876605 Preparation of plasma or serum sample from whole blood |
03/02/1999 | US5876593 Magnetic immobilization and manipulation of biological entities |
03/02/1999 | US5875768 Method and arrangement for determining the sensitivity of a hydrocarbon sensor for an internal combustion engine |
03/02/1999 | CA2246191A1 Method of checking the slump of a ready-mix concrete load |
03/02/1999 | CA2242315A1 Mecb |
03/02/1999 | CA2242252A1 Dexb |
03/02/1999 | CA2241417A1 Novel ffh |
03/02/1999 | CA2214461A1 Screening method for determining individuals at risk of developing diseases associated with different polymorphic forms of wildtype p53 |
03/02/1999 | CA2069772C A device for the safe removal of blood from a supply vessel |
03/02/1999 | CA2058769C Methods for determining phospholipids and antibodies thereof |
03/02/1999 | CA1340413C Method of preparing phosphodiester conjugates useful for immunoactive liposomes |
03/01/1999 | CA2242311A1 Novel compounds |
02/28/1999 | CA2245016A1 On-line rheometer device |
02/28/1999 | CA2241427A1 Novel pyrr homolog |
02/28/1999 | CA2241424A1 Novel ftsy |
02/28/1999 | CA2241420A1 Novel folc |
02/28/1999 | CA2241400A1 Ftsy |
02/27/1999 | CA2233681A1 Novel div1b |
02/26/1999 | CA2241431A1 Novel spoiiie |
02/26/1999 | CA2241410A1 Pth |
02/25/1999 | WO1999009455A1 Multi parameter scanner |
02/25/1999 | WO1999009417A2 Method of drug selection |
02/25/1999 | WO1999009416A2 Method of drug selection |
02/25/1999 | WO1999009415A1 Scintillation proximity test |
02/25/1999 | WO1999009414A1 Use of recombinant envelope proteins for diagnosing the dengue virus |
02/25/1999 | WO1999009413A1 Anti-tryptase detection as a diagnostic for inflammatory diseases |
02/25/1999 | WO1999009412A1 Functional fragments of hiv-1 vpr protein and methods of using the same |
02/25/1999 | WO1999009411A1 NOVEL COMPOUND 2-AMINO-3-[2-(α-MANNOPYRANOSYL)INDOL-3-YL]PROPIONIC ACID, PROCESS FOR PREPARING THE SAME, AND METHOD FOR INSPECTING FUNCTION OF LIVING BODY WITH THE NOVEL COMPOUND |
02/25/1999 | WO1999009410A2 Rapid assay for simultaneous detection and differentiation of antibodies to hiv |
02/25/1999 | WO1999009409A1 Housing for a flammable gas detector |
02/25/1999 | WO1999009394A1 Apparatus for performing assays at reaction sites |
02/25/1999 | WO1999009390A1 A high quality, continuous throughput, tissue fixation-dehydration-fat removal-impregnation method |
02/25/1999 | WO1999009388A2 Method and apparatus for real time gas analysis and medical fluids monitoring |
02/25/1999 | WO1999009217A1 Methods and compositions for detection or quantification of nucleic acid species |
02/25/1999 | WO1999009210A2 Mutation within the connexin 26 gene responsible for prelingual non-syndromic deafness and method of detection |
02/25/1999 | WO1999009208A1 Method and reagent for monitoring apoptosis and distinguishing apoptosis from necrosis |
02/25/1999 | WO1999009206A1 Methods for using granzymes and binding molecules thereof for treating diseases characterized by abnormal apoptosis |
02/25/1999 | WO1999009204A1 Methods for the high-resolution identification of solvent-accessible amide hydrogens in polypeptides |
02/25/1999 | WO1999009203A1 Chromatographic method for mutation detection using mutation site specifically acting enzymes |
02/25/1999 | WO1999009201A2 Biosensor with immobilized bioluminescent microorganisms |
02/25/1999 | WO1999009199A2 Elongation factor-2 kinase (ef-2 kinase) and methods of use therefor |
02/25/1999 | WO1999009186A2 Polypeptide nucleic sequences exported from mycobacteria, vectors comprising same and uses for diagnosing and preventing tuberculosis |
02/25/1999 | WO1999009179A2 Antigen constructs useful in the detection and differentiation of antibodies to hiv |
02/25/1999 | WO1999009177A2 Papilloma virus, agents for the detection thereof and for the therapy of the diseases caused by said virus |
02/25/1999 | WO1999009176A1 Neisseria lactoferrin binding protein |
02/25/1999 | WO1999009172A1 Method for identifying and locating expressed epil peptides, coded by the insl4 gene and their uses |
02/25/1999 | WO1999009166A2 Prostate tumor polynucleotide and antigen compositions |
02/25/1999 | WO1999009165A1 Trail receptors, nucleic acids encoding the same, and methods of use thereof |
02/25/1999 | WO1999009162A2 Delayed progression to aids by a missense allele of the ccr2 gene |
02/25/1999 | WO1999009156A2 Protease-related protein |
02/25/1999 | WO1999009155A1 70 human secreted proteins |
02/25/1999 | WO1999009149A1 Three-dimensional polymer matrices |
02/25/1999 | WO1999009148A1 Crystals of hepatitis c virus helicase or fragments thereof comprising a helicase binding pocket |
02/25/1999 | WO1999009146A1 Human serum inducible kinase (snk) |